AI assistant
Sending…
Actinium Pharmaceuticals, Inc. — Director's Dealing 2017
Jan 3, 2017
34570_dirs_2017-01-03_902f07ea-3602-464c-bbe2-299e3d3a3791.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Actinium Pharmaceuticals, Inc. (ATNM)
CIK: 0001388320
Period of Report: 2016-12-30
Reporting Person: SETH SANDESH (Director, Executive Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-12-30 | Common stock | P | 5000 | $0.88 | Acquired | 35000 | Direct |
More from Actinium Pharmaceuticals, Inc.
Regulatory Filings
2026
May 29
Annual Report
2026
Mar 30
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Feb 13
Declaration of Voting Results & Voting Rights Announcements
2025
Nov 26
Interim / Quarterly Report
2025
Nov 14
Annual Report
2025
Nov 5
Proxy Solicitation & Information Statement
2025
Nov 5
Director's Dealing
2025
Aug 20
Interim / Quarterly Report
2025
Aug 8